CN107141310A - 一种新型抗菌锌配合物的制备方法及其应用 - Google Patents
一种新型抗菌锌配合物的制备方法及其应用 Download PDFInfo
- Publication number
- CN107141310A CN107141310A CN201610642811.0A CN201610642811A CN107141310A CN 107141310 A CN107141310 A CN 107141310A CN 201610642811 A CN201610642811 A CN 201610642811A CN 107141310 A CN107141310 A CN 107141310A
- Authority
- CN
- China
- Prior art keywords
- complex
- pbbi
- antibacterial
- novel antibacterial
- bisbenzimidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000011701 zinc Substances 0.000 claims abstract description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000588724 Escherichia coli Species 0.000 claims abstract description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 7
- 239000003446 ligand Substances 0.000 claims abstract description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 7
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 6
- -1 Zn (II) ions Chemical class 0.000 claims abstract description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 4
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims abstract description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000013078 crystal Substances 0.000 claims description 12
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- AJKCBQALZBXPGF-UHFFFAOYSA-N 1-[5-(benzimidazol-1-yl)pyridin-2-yl]benzimidazole Chemical compound N1=C(C=CC(=C1)N1C=NC2=C1C=CC=C2)N1C=NC2=C1C=CC=C2 AJKCBQALZBXPGF-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 150000003851 azoles Chemical class 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 claims 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 abstract description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052725 zinc Inorganic materials 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 238000010189 synthetic method Methods 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 150000003222 pyridines Chemical class 0.000 abstract 1
- 238000000935 solvent evaporation Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/06—Zinc compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种新型抗菌锌配合物，属于抗菌配合物制备方法及其应用技术领域。制备方法为：利用溶剂挥发法，在95%乙醇中，1,1'‑(吡啶‑2,5‑二基)双苯并咪唑与七水合硫酸锌作用，得到具有抗菌活性的新型含金属锌的配合物，该属于三斜晶系，空间群为Pī，晶胞参数为：a=15.706(6)Å,b=16.114(6)Å，c=17.160(7)Å，a=91.418(7)°，β=115.716(7)°，γ=103.594(7)°，V=3763(2)Å3。不对称单元中包含两个Zn(II)离子、四个PBBI（1,1'‑(吡啶‑2,5‑二基)双苯并咪唑）、两个硫酸根、四个配位水分子和5个未配位水分子，Zn1和Zn2分别与来自两个PBBI配体中的氮原子、两个硫酸根中的氧原子和两个水分子中的氧原子配位，形成扭曲的八面体。本发明提出的一种新型抗菌锌配合物，合成方法简单、操作简便、稳定性强，能够有效抑制革兰阴性菌大肠杆菌（ATCC25922）、铜绿假单胞菌和革兰阳性菌金黄色葡萄球菌（ATCC25923），具有可进一步开发应用前景。
Description
技术领域
本发明涉及配合物制备方法及其应用技术领域，尤其是涉及一种抗菌配合物的制备方法及其应用。
背景技术
长期以来，由于滥用抗生素导致细菌耐药，产生所谓的“超级细菌”，已成为一个全球医疗卫生难题，使得临床抗菌药物受到了极大的挑战，合成新型抗菌药是解决当前细菌多药耐药性的关键。配合物能够有效催化细菌细胞膜发生过氧化作用，破坏细菌细胞膜，从而导致细菌死亡而达到抗菌作用。因此，构筑新型配合物作为抗菌药物是解决细菌耐药性问题的重要途径之一，配合物作为抗菌药具有显著的优势。
基于上述原因，本发明人制备了一种新型抗菌锌配合物，具有良好的体外抗菌活性，能够有效抑制革兰阴性菌大肠杆菌（ATCC25922）、铜绿假单胞菌和革兰阳性菌金黄色葡萄球菌（ATCC25923）。
发明内容
本发明的目的在于提供一种新型抗菌锌配合物的制备方法，其合成方法简单、操作简便、稳定性强以及抗菌活性较强。
本发明的目的是通过如下技术方案实现的：一种新型抗菌锌配合物，分子式为Zn2(PBBI)4(SO4)2(H2O)2·5H2O，其中，PBBI为1,1'-(吡啶-2,5-二基)双苯并咪唑，其结构式为：。
所述一种新型抗菌锌配合物属于三斜晶系，空间群为Pī，晶胞参数为：a = 15.706(6)Å, b = 16.114(6)Å，c = 17.160(7)Å，a = 91.418(7)°，β = 115.716(7)°，γ =103.594(7)°，V = 3763(2)Å3。
所述一种新型抗菌锌配合物的基本结构单元中包含两个Zn(II)离子、四个PBBI（1,1'-(吡啶-2,5-二基)双苯并咪唑）、两个硫酸根、四个配位水分子和5个未配位水分子。Zn1和Zn2分别与来自两个PBBI配体中的氮原子、两个硫酸根中的氧原子和两个水分子中的氧原子配位，形成扭曲的八面体，该配合物中其中一个硫酸根存在无序情况。
所述一种新型抗菌锌配合物的制备方法：称取0.0125 mmol配体1,1'-(吡啶-2,5-二基)双苯并咪唑超声溶解于95%乙醇中，再称取0.0125mmol七水合硫酸锌超声溶解于95%乙醇中，将两种溶液充分混合，再超声10-20min，过滤，滤液于室温下缓慢挥发溶剂，一周后得到无色块状晶体，收集晶体，依次经过95%乙醇洗涤、干燥处理，得到目标物。
所述一种新型抗菌锌配合物具有良好的抗菌效果，对革兰阴性菌大肠杆菌（ATCC25922）、铜绿假单胞菌和革兰阳性菌金黄色葡萄球菌（ATCC25923）表现出较强的抑制作用。
本发明的有益效果是：本发明提出的一种新型抗菌锌配合物，合成方法简单、操作简便、稳定性强，能够有效抑制革兰阴性菌大肠杆菌（ATCC25922）、铜绿假单胞菌和革兰阳性菌金黄色葡萄球菌（ATCC25923）。本发明提出的一种新型抗菌锌配合物作为抗菌剂具有可进一步开发应用前景。
附图说明
图1为本发明所提出的一种新型抗菌锌配合物的结构图，为了清晰起见，省略了氢原子和未配位溶剂分子。
图2为本发明所提出的一种新型抗菌锌配合物的X-粉末衍射图谱。
图3为本发明所提出的一种新型抗菌锌配合物的热重曲线图。
具体实施方式
下面结合具体实施方式对本发明作进一步说明，需说明的是，本发明要求保护的范围并不局限于实施例表述的范围。
所述一种新型抗菌锌配合物的制备方法：称取1,1'-(吡啶-2,5-二基)双苯并咪唑（0.0125 mmol，3.89mg）超声溶解于5 mL 95%乙醇中，再称取七水合硫酸锌（0.0125 mmol，3.59mg）超声溶解于5 mL 95%乙醇中，然后将两种溶液充分混合，再超声振荡10-20min，过滤，滤液置于小试管中，用保鲜膜封住试管口，在保鲜膜上用针扎几个小孔，于室温下缓慢挥发溶剂，一周后得到无色块状晶体，收集晶体，晶体用95%乙醇洗涤，干燥，得到目标物，产率约56%。
所述配合物的晶体结构表征为：选取大小合适的单晶在室温下进行X-射线衍射实验。单晶X-射线数据是由石墨单色器Mo Kα（λ = 0.71073 Å）作为放射源，在Bruker APEX-II CCD单晶衍射仪上采集的，所得到的数据都应用了经验吸收校正。晶体结构采用SHELXTL-97 程序通过直接法解出，运用F 2全矩阵最小二乘方法进行了精修。所有的非氢原子的各向异性都进行了精修，所有氢原子的位置都是通过计算得到的。配合物的晶体学数据和结构精修结果列于表1中，部分键长和键角列于表2中，配合物的结构见图1。
表1 配合物的主要晶体学数据和结构精修结果
R 1 =ΣllF0l-lFcll/ΣlF0l; wR 2 =Σ[w(F0 2–FC 2)2]/ Σ[w(F0 2)2]1/2
表2配合物的部分键长（Å）和键角（º）
| Zn(1)-O(6) 2.095(6) | Zn(1)-O(3) 2.096(5) |
| Zn(1)-N(6) 2.111(6) | Zn(1)-O(2W) 2.119(5) |
| Zn(1)-O(1W) 2.127(6) | Zn(1)-N(1) 2.134(7) |
| Zn(2)-O(4W) 2.085(6) | Zn(2)-N(16) 2.108(6) |
| Zn(2)-N(11) 2.128(6) | Zn(2)-O(2) 2.130(5) |
| Zn(2)-O(7) 2.130(8) | Zn(2)-O(3W) 2.145(7) |
| O(3)-Zn(1)-O(1W) 83.8(2) | O(3)-Zn(1)-N(6) 174.6(3) |
| O(2)-Zn(2)-O(7) 84.6(3) | O(4W)-Zn(2)-O(3W) 175.3(2) |
所述配合物X-粉末衍射（PXRD）图谱与模拟图谱吻合较好，说明该配合物为纯相，为其作为抗菌剂的应用提供了保证，配合物的X-粉末衍射（PXRD）图谱见图2，所用仪器为TD-3500 X-粉末衍射仪。
所述配合物在100-240°发生第一次失重，失去未配位水分子，未配位水分子的失去不会导致整体结构的变化。500°以后开始骨架分解。因此在500°以内其结构稳定。(仪器型号:NETZSCH5 STA 449C)。
由上述结构表征可知，所述配合物属于三斜晶系，空间群为Pī，晶胞参数为：a =15.706(6)Å, b = 16.114(6)Å，c = 17.160(7)Å，a = 91.418(7)°，β = 115.716(7)°，γ =103.594(7)°，V = 3763(2)Å3。不对称单元中包含两个Zn(II)离子、四个PBBI（1,1'-(吡啶-2,5-二基)双苯并咪唑）、两个硫酸根、四个配位水分子和5个未配位水分子。Zn1和Zn2分别与来自两个PBBI配体中的氮原子、两个硫酸根中的氧原子和两个水分子中的氧原子配位，形成扭曲的八面体。
所述配合物的体外抗菌活性测试按照美国国家实验室标准委员会（NCCLS）推荐的标准测试方法进行，测试菌种为革兰阴性菌大肠杆菌（ATCC25922）、铜绿假单胞菌和革兰阳性菌金黄色葡萄球菌（ATCC25923）。
体外抗菌活性测试结果表明，所述配合物对大肠杆菌（ATCC25922）的MIC为32mg/mL，对铜绿假单胞菌的MIC为16mg/mL，对金黄色葡萄球菌（ATCC25923）的MIC为16mg/mL。
Claims (3)
1.一种新型抗菌锌配合物，其特征在于：分子式为Zn2(PBBI)4(SO4)2(H2O)2·5H2O，其中，PBBI为1,1'-(吡啶-2,5-二基)双苯并咪唑，配合物的结构为：
；
其中结构单元中包含两个Zn(II)离子、四个PBBI（1,1'-(吡啶-2,5-二基)双苯并咪唑）、两个硫酸根、四个配位水分子和5个未配位水分子，Zn1和Zn2分别与来自两个PBBI配体中的氮原子、两个硫酸根中的氧原子和两个水分子中的氧原子配位，形成扭曲的八面体。
2.根据权利要求1所述一种新型抗菌锌配合物的制备方法，其特征在于：称取0.0125mmol配体1,1'-(吡啶-2,5-二基)双苯并咪唑超声溶解于95%乙醇中，再称取0.0125mmol七水合硫酸锌超声溶解于95%乙醇中，将两种溶液充分混合，再超声10-20min，过滤，滤液于室温下缓慢挥发溶剂，一周后得到无色块状晶体，收集晶体，依次经过95%乙醇洗涤、干燥处理，得到目标物。
3.根据权利要求1所述一种新型抗菌锌配合物，其特征在于：具有良好的体外抗菌活性，其中对大肠杆菌（ATCC25922）的MIC为32mg/mL，对铜绿假单胞菌的MIC为16mg/mL，对金黄色葡萄球菌（ATCC25923）的MIC为16mg/mL。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610642811.0A CN107141310A (zh) | 2016-08-08 | 2016-08-08 | 一种新型抗菌锌配合物的制备方法及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610642811.0A CN107141310A (zh) | 2016-08-08 | 2016-08-08 | 一种新型抗菌锌配合物的制备方法及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107141310A true CN107141310A (zh) | 2017-09-08 |
Family
ID=59783336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610642811.0A Pending CN107141310A (zh) | 2016-08-08 | 2016-08-08 | 一种新型抗菌锌配合物的制备方法及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107141310A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320642A (zh) * | 2018-12-14 | 2020-06-23 | 南京大学 | 一种具有抗菌活性的萘普生锌配合物及其制备方法 |
| CN111658646A (zh) * | 2020-06-28 | 2020-09-15 | 河南工业大学 | 2,6-双(2-苯并咪唑基)吡啶在制备耐碳青霉烯类铜绿假单胞菌感染药物中的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099190A1 (en) * | 2003-05-09 | 2004-11-18 | Astrazeneca Ab | Novel substituted benzimidazole derivatives |
| WO2011151621A1 (en) * | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| CN103923110A (zh) * | 2014-04-03 | 2014-07-16 | 哈尔滨工业大学 | 具有抗菌活性的苯并咪唑衍生物金属配合物及其制备方法 |
| CN105311020A (zh) * | 2015-11-25 | 2016-02-10 | 临沂大学 | 一种双苯并咪唑胺类化合物及其制备方法 |
-
2016
- 2016-08-08 CN CN201610642811.0A patent/CN107141310A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099190A1 (en) * | 2003-05-09 | 2004-11-18 | Astrazeneca Ab | Novel substituted benzimidazole derivatives |
| WO2011151621A1 (en) * | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| CN103923110A (zh) * | 2014-04-03 | 2014-07-16 | 哈尔滨工业大学 | 具有抗菌活性的苯并咪唑衍生物金属配合物及其制备方法 |
| CN105311020A (zh) * | 2015-11-25 | 2016-02-10 | 临沂大学 | 一种双苯并咪唑胺类化合物及其制备方法 |
Non-Patent Citations (4)
| Title |
|---|
| N M. AGHATABAY. ET AL: ""Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand"", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
| 丁锦华等: "《植物保护辞典》", 30 November 1995, 江苏科学技术出版社 * |
| 孟江平等: ""含苯并咪唑片段结构的抗微生物药物研究新进展"", 《中国抗生素杂志》 * |
| 张英等: ""苯并咪唑类化合物杀菌活性的研究进展"", 《农药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320642A (zh) * | 2018-12-14 | 2020-06-23 | 南京大学 | 一种具有抗菌活性的萘普生锌配合物及其制备方法 |
| CN111658646A (zh) * | 2020-06-28 | 2020-09-15 | 河南工业大学 | 2,6-双(2-苯并咪唑基)吡啶在制备耐碳青霉烯类铜绿假单胞菌感染药物中的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Supriya et al. | A cyclic supramolecular (H 2 O) 4 cluster in an unusual Fe 3 complex that aggregates to {Fe 3} n with a zig-zag chainlike structure | |
| CN105985362B (zh) | 一种制备沸石咪唑酯骨架结构材料的方法 | |
| Costa et al. | Silver (I) and gold (I) complexes with penicillamine: Synthesis, spectroscopic characterization and biological studies | |
| CN107141310A (zh) | 一种新型抗菌锌配合物的制备方法及其应用 | |
| Luo et al. | An NIF-doped ZIF-8 hybrid membrane for continuous antimicrobial treatment | |
| Wilson et al. | Geometrically specific multidentate ligands and their complexes. I. A nickel (II) complex of the potentially heptadentate Schiff base derived from 2, 2'2''-triaminotriethylamine and 2-pyridinecarboxaldehyde | |
| CN110115272A (zh) | 一种Cu纳米粒子耦合石墨烯水凝胶复合材料及其制备方法和应用 | |
| Huang et al. | Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms | |
| CN102775291A (zh) | 一种大黄素衍生物及其在制备抗菌药物中的应用 | |
| Zhu et al. | pH-dependent synthesis of two three-dimensional cobalt-based metal organic frameworks with antibacterial activity and dye adsorption | |
| CN108432804A (zh) | 一种复合抑菌剂及其制备方法与应用 | |
| Zou et al. | Two metal complex derivatives of pyridine thiazole ligand: synthesis, characterization and biological activity | |
| Leong et al. | Coordination isomers of biological iron transport compounds. II. Optical isomers of chromic desferriferrichrome and desferriferrichrysin | |
| Tabong et al. | Synthesis, Crystal Structure, and Antimicrobial Properties of [Diaquabis (hexamethylenetetramine) diisothiocyanato‐κN] nickel (II) Complex | |
| Wang et al. | The rational design of four multifunctional octamolybdate-based complexes for detecting different ions and removing organic dyes from aqueous solution | |
| Yue et al. | pH-dependent assembly of metal–organic hybrid compounds based on octamolybdates and a new flexible multidentate ligand | |
| CN109221104A (zh) | 一种含银碳点、制备方法及其应用 | |
| Palicová et al. | Synthesis, spectral properties, crystal structures and antimicrobial effects of copper (II) pyridinecarboxylate adducts with chelating ligands | |
| CN106632505A (zh) | 一种质子导电金属有机骨架结构化合物及其制备方法 | |
| CN102573859B (zh) | 银/聚缩二胍配合物、其制备方法以及含有所述银/聚缩二胍配合物作为活性成分的抗细菌组合物 | |
| Kannan et al. | Structure of human carbonic anhydrase B: I. Crystallization and heavy atom modifications | |
| Muthukkumar et al. | Macrocyclic Schiff base metal complexes derived from isatin: structural activity relationship and DFT calculations | |
| Kadomtseva et al. | Prospects of Using Metal Cations to Develop Antimicrobial Complexes | |
| CN104860969B (zh) | 一种具有吸附富集剧毒农药能力的金属‑有机框架材料及其制备方法与用途 | |
| Raman et al. | Novel metal-based antimicrobial agents of copper (II) complexes: Synthesis, spectral characterization and DNA interaction study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170908 |